Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Zigeuner

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Journal of Clinical Pathology|February 10, 2015
Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinomaGeorg C Hutterer, N Sobolev, Georg C Ehrlich, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 14, 2012
Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decadesMehrad Adibi, Ramy Youssef, Shahrokh F Shariat, et al.
Journal of Clinical Pathology|April 12, 2015
Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinomaOrietta Dalpiaz, Martin Pichler, Edvin Mrsic, et al.
Urology|December 21, 2010
Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinomaRamy F Youssef, Shahrokh F Shariat, Yair Lotan, et al.
BJU International|September 24, 2013
Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinomaOrietta Dalpiaz, Georg C Ehrlich, Sebastian Mannweiler, et al.
Cancer|January 22, 2009
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma CollaborationVitaly Margulis, Shahrokh F Shariat, Surena F Matin, et al.
Urologia Internationalis|December 25, 2015
The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and GermanyChristian Meyer, Jens Hansen, Andreas Becker, et al.
Frontiers in Surgery|June 29, 2026
Clinically significant tumor histology in suspected primary bladder cancer: is every transurethral resection necessary?Conrad Leitsmann, Alexander Stephan Reese, Richard Zigeuner, et al.
Urologic Oncology|May 8, 2019
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation studyGeorg C Hutterer, Florian Posch, Lorenz Buser, et al.
Cancer|January 31, 2007
Prognostic ability of simplified nuclear grading of renal cell carcinomaNathalie Rioux-Leclercq, Pierre I Karakiewicz, Quoc-Dien Trinh, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Journal of Clinical Pathology|February 10, 2015
Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinomaGeorg C Hutterer, N Sobolev, Georg C Ehrlich, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 14, 2012
Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decadesMehrad Adibi, Ramy Youssef, Shahrokh F Shariat, et al.
Journal of Clinical Pathology|April 12, 2015
Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinomaOrietta Dalpiaz, Martin Pichler, Edvin Mrsic, et al.
Urology|December 21, 2010
Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinomaRamy F Youssef, Shahrokh F Shariat, Yair Lotan, et al.
BJU International|September 24, 2013
Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinomaOrietta Dalpiaz, Georg C Ehrlich, Sebastian Mannweiler, et al.
Cancer|January 22, 2009
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma CollaborationVitaly Margulis, Shahrokh F Shariat, Surena F Matin, et al.
Urologia Internationalis|December 25, 2015
The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and GermanyChristian Meyer, Jens Hansen, Andreas Becker, et al.
Frontiers in Surgery|June 29, 2026
Clinically significant tumor histology in suspected primary bladder cancer: is every transurethral resection necessary?Conrad Leitsmann, Alexander Stephan Reese, Richard Zigeuner, et al.
Urologic Oncology|May 8, 2019
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation studyGeorg C Hutterer, Florian Posch, Lorenz Buser, et al.
Cancer|January 31, 2007
Prognostic ability of simplified nuclear grading of renal cell carcinomaNathalie Rioux-Leclercq, Pierre I Karakiewicz, Quoc-Dien Trinh, et al.
Pageof 17